INTRODUCTION
Approximately 3% of patients undergoing screening colonoscopy will have a polyp ≥2 cm in diameter ( 1 ) . Most of these "complex polyps" are too large or too fl at to remove with standard polypectomy. Management of challenging lesions may include surgical referral for partial colectomy. Th is practice, however, is outdated. With recent advances in endoscopic mucosal resection (EMR), over 90% of advanced polyps that lack overt features of cancer can be removed during outpatient colonoscopy, regardless of their size ( 2 ) .
In principle, all benign polyps should be removed endoscopically, not with colectomy. Colonoscopic resection is recommended as the fi rst-line treatment by societies and guidelines worldwide, including the US Multi-society Task Force on Colorectal Cancer (2) (3) (4) (5) , and is endorsed by colorectal surgeons ( 5, 6 ) ; it is both more cost-eff ective than surgery, and associated with lower morbidity and mortality ( 7, 8 ) . A recent analysis of National Surgical Quality Improvement Program (NSQIP) data found a 30-day mortality of 0.7% for surgical resection of non-malignant polyps, which increased to 3% among patients above age 80 ( 9 ) . By comparison, the 30-day mortality associated with endoscopic resection was only 0.08% in a review of 6440 patients ( 10 ) and zero in a prospective study of 1050 patients ( 11 ) . In other words, overall surgical mortality for management of benign polyps is nearly 10-fold higher than for endoscopic resection.
Sometimes, colectomy can off er a more defi nitive solution, such as in patients with numerous polyps or polyps involving the appendiceal orifi ce or ileocecal valve, suspected Lynch syndrome, or dysplastic colitis associated lesions. However, even these circumstances do not necessarily preclude successful endoscopic 
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management, and consultation with an expert "resectionist" prior to considering colectomy is appropriate. While endoscopic solutions for patients with non-malignant colorectal polyps have evolved, practice patterns in the US have been slow to follow. In a recent report, nearly one in three elective colon resections had been performed for treatment of benign polyps ( 12 ) . In order to improve the quality of care for these patients, some signifi cant barriers will need to be addressed ( Table 1 ) .
PRESUMPTION OF MALIGNANCY: ALL BIG POLYPS ARE NOT MALIGNANT
"Th at polyp is huge-it must have cancer in it!" Endoscopists may falsely presume that an advanced polyp is malignant and unsuitable for endoscopic resection ( 13 ) . With high-defi nition endoscopes and skill in visual diagnosis, however, endoscopically curable polyps can generally be identifi ed by their appearance. Universal skills in optical diagnosis are key in complex polyp management. Endoscopic training must therefore emphasize lesion characterization by gross morphology and surface features (Paris and Narrow-band imaging International Colorectal Endoscopic (NICE) classifi cations), which should be included in procedure reports.
EXPECTATIONS: ALL POLYPS ARE NOT THE SAME
"My patient will be upset if I do not try to remove this polyp. " Many endoscopists and patients share a presumption that any polyp discovered at a screening colonoscopy should be removed during the same procedure. A more reasonable expectation would be that certain fi ndings may require treatment at another session. It is usually wisest to treat complex polyps at a dedicated procedure aft er the plan and risks have been reviewed Table 1 . Barriers and possible solutions to optimize care for patients with complex polyps
Barriers
Possible solutions
• Inaccurate visual diagnosis.
• Develop educational programs in visual diagnosis for practicing endoscopists who perform screening colonoscopy.
• Presumption of malignancy based on size.
• Automatic prompts for gross morphology (Paris classifi cation) and surface morphology (e.g., NICE) for all polyps ≥20 mm in procedure reporting software.
• Lack of confi dence in assessment of submucosal invasion.
• Increased emphasis on visual diagnosis on GI board exams.
• Uncertainty regarding which lesions are eligible for endoscopic resection.
• Creation of new standardized methods of information transfer for consulting physician to review high resolution endoscopic images.
• Expectation that all polyps can and should be resected during initial screening procedure.
• Inform patients that if a large polyp is found, a separate procedure may be needed to remove it.
• Assumption that all colonoscopists should be profi cient in EMR.
• Develop competency criteria to perform EMR.
• Ingrained habits and referral patterns.
• Better promotion of EMR centers of excellence by GI societies.
• Assumption that surgery is the only alternative to polypectomy at time of screening exam.
• Creation of guidelines for management of patients with complex polyps to drive high quality care.
• Limited availability of EMR experts • Training programs, such as ASGE STAR program
• Inability to search for EMR experts by region • Creation of a searchable database of endoscopic resection centers of excellence
• Distance to nearest tertiary center • Shared decision-making with patients regarding willingness to travel to avoid surgery
• Poor compensation for EMR procedures • Payers endorse and pay for a second opinion by an expert prior to approval of surgery for benign colonic lesions.
• Payers endorse and pay for a second therapeutic colonoscopy when complex polyps are found at a screening exam.
• Payers provide time-based reimbursement for complex resections, especially prolonged EMR and ESD (endoscopic submucosal dissection) procedures.
• Reimbursement schemes that place equal value on endoscopic and surgical resection of benign polyps.
• Absence of quality metrics for management of complex polyps • Creation of practice-level quality metrics such as proportion of benign polyps ≥20 mm removed endoscopically.
• EMR experts should track performance, such as case volume, complication rates, and residual neoplasia rates at follow-up.
ASGE, American Society of Gastrointestinal Endoscopy; EMR, endoscopic mucosal resection; NICE, Narrow-band imaging International Colorectal Endoscopic classifi cation; STAR, Skills, Training, Assessment and Reinforcement.
THE RED SECTION
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with the patient, with ample time allotted, with all necessary equipment at hand, and with adequately trained staff present.
TRAINING: EXPERTISE IN COLONOSCOPY IS NOT THE SAME AS EXPERTISE IN EMR
"I doubt that anyone could resect that polyp!" Performing high quality EMR requires training and high procedural volumes to achieve and maintain competency. In one report, at least 100 colorectal EMR procedures were required to attain adequately high rates of technical success ( 14 ) . Complex polypectomies performed by specialist endoscopists are associated with better outcomes including a lower risk of incomplete resection ( 15, 16 In the US, colonoscopy is performed by gastroenterologists, surgeons, and primary care physicians, and not all are familiar with the spectrum of lesions amenable to EMR or other advanced mucosal resection techniques. Some may lack access to a local EMR expert, or not know how to locate the nearest high-volume center of excellence. Th ough the availability of endoscopists with EMR expertise is limited in some regions of the US, patients are oft en motivated to travel a considerable distance to avoid a colectomy and its attendant risks.
GI societies could help identify means for recognizing centers of excellence, and communicate this information as a resource for referring physicians.
REIMBURSEMENT: ALL PROCEDURES ARE NOT EQUITABLY REIMBURSED
"Why should I spend my time on that polyp when I will not get reimbursed for the time, and it will delay the other patients on my schedule? I will just refer them to surgery. " As compared to performing a simple polypectomy, a diffi cult and time-consuming EMR is oft en not reimbursed in proportion 
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to the work involved. Th us, for the time-pressured endoscopist, referral to a surgeon is a more cost-eff ective use of their time than working on a challenging polyp. Insurance companies and regulatory bodies can powerfully infl uence physician behavior, through compensation schedules and pre-authorizations. However, the current fi nancial climate does not incentivize endoscopic resection over colectomy. Compared to EMR, surgery with a laparoscopic hemicolectomy (CPT44204) generates a 2017 Medicare professional reimbursement nearly fi ve times greater than that for colonic EMR (CPT 45390). Until reimbursement is more proportionate to the time and eff ort required, advanced endoscopic resection procedures will not reach their full potential in the US. Health systems participating in alternative payment models with downside fi nancial risk (e.g., accountable care organizations) should fi nd EMR fi nancially attractive. Savvy endoscopists working within these systems may be able to negotiate more favorable remuneration for this cost-eff ective service.
High quality care for patients with complex polyps
What can referring physicians do to ensure the highest quality of care ( Figure 1 )?
1 . Carefully assess and characterize lesions (Paris classifi cation, NICE) with high-defi nition endoscopy. High quality digital images should be provided to the consulting physician to counsel patients and plan their resection procedures ( Figure 2 ). 2 . Avoid attempts at removal when in doubt. Th e largest contributor to inferior EMR outcomes is the incomplete removal of a lesion prior to referral ( Figure 3 ) ( 17 ) . Biopsies can be avoided except when signs of invasive cancer are present, such as depressed morphology and loss of regular surface or vascular pattern ( Figure 4 ). Biopsies can cause submucosal fi brosis and subsequent non-lift ing properties. Aggressive biopsies and partial removal reduce the chance of a successful one-stage resection, increase risk of bleeding and perforation, and unnecessarily drive up procedure times, costs, and follow-up examinations. 3 . Be cautious placing tattoos near the lesion. An accurate description and high quality photo is preferred over a tattoo. Tattoos may actually complicate resection attempts because the carbon tends to track several centimeters from the injection site and underneath the lesion, leading to submucosal fi brosis ( Figure 5 ). If a tattoo is placed, the marking should be on the opposite wall 5 cm distal to the lesion. 4 . Only refer patients for surgical resection when invasive cancer is present. "Intramucosal carcinoma" is not invasive cancer, but rather an endoscopically curable lesion whose misleading name oft en leads to an unnecessary surgical referral. 5 . Counsel patients about the option of endoscopic resection, even when treatment requires travelling a considerable distance.
Endoscopic resection techniques have advanced substantially in the last decade. Most complex benign polyps can now be safely resected endoscopically, sparing patients the higher risks, and costs of colectomy. Gastroenterologists, surgeons, professional societies, and payers should work together to promote endoscopic resection as the treatment of choice for all benign colorectal polyps.
